Cardinal Health (CAH) Stock Forecast & Price Target

Compare

2,413 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CAH Analyst Ratings

Strong Buy

12 Buy

1 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Cardinal

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CAH Stock 12 Month Forecast

Average Price Target

$249.92

▲(13.19% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is $249.92 with a high forecast of $270.00 and a low forecast of $235.00. The average price target represents a 13.19% change from the last price of $220.79.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"121":"$121","196":"$196","271":"$271","158.5":"$158.5","233.5":"$233.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":270,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$270.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":249.9230769230769,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$249.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":235,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$235.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[121,158.5,196,233.5,271],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,218.93,222.85846153846154,226.78692307692307,230.7153846153846,234.64384615384617,238.5723076923077,242.50076923076924,246.42923076923077,250.3576923076923,254.28615384615387,258.2146153846154,262.14307692307693,266.07153846153847,{"y":270,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,218.93,221.3140828402367,223.69816568047338,226.08224852071007,228.46633136094675,230.85041420118344,233.23449704142013,235.61857988165679,238.00266272189347,240.38674556213016,242.77082840236685,245.15491124260353,247.53899408284022,{"y":249.9230769230769,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,218.93,220.16615384615386,221.4023076923077,222.63846153846154,223.8746153846154,225.11076923076922,226.34692307692308,227.58307692307693,228.81923076923078,230.0553846153846,231.29153846153847,232.52769230769232,233.76384615384615,{"y":235,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":122.127,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.875,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.929,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":144.256,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":153.891,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.457,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.105,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147.927,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157.537,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":190.295,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":207.483,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":204.989,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":218.93,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$270.00

Average Price Target$249.92

Lowest Price Target$235.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Lisa Gill

J.P. Morgan

$243

Hold

10.06%

Upside

Reiterated

02/10/26

Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Biogen (NASDAQ: BIIB) and Quest Diagnostics (NYSE: DGX)

Charles Rhyee

TD Cowen

$233→$251

Buy

13.68%

Upside

Reiterated

02/10/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Cardinal Health (NYSE: CAH)

Steven Valiquette

Mizuho Securities

$235

Buy

6.44%

Upside

Reiterated

02/10/26

Mizuho Securities Keeps Their Buy Rating on Cardinal Health (CAH)

Stephen Baxter

Wells Fargo

$237→$256

Buy

15.95%

Upside

Reiterated

02/10/26

Cardinal Health price target raised to $256 from $237 at Wells FargoCardinal Health price target raised to $256 from $237 at Wells Fargo

Erin Wright

Morgan Stanley

$245→$255

Buy

15.49%

Upside

Reiterated

02/06/26

Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and Cardinal Health (NYSE: CAH)

Eric Coldwell

Robert W. Baird

$250→$252

Buy

14.14%

Upside

Reiterated

02/06/26

Cardinal Health price target raised to $252 from $250 at BairdCardinal Health price target raised to $252 from $250 at Baird

Glen Santangelo

Barclays

$243

Buy

10.06%

Upside

Reiterated

02/06/26

Barclays Remains a Buy on Cardinal Health (CAH)

Kevin Caliendo

UBS

$250→$260

Buy

17.76%

Upside

Reiterated

02/06/26

Cardinal Health price target raised to $260 from $250 at UBSCardinal Health price target raised to $260 from $250 at UBS

Elizabeth Anderson CFA

Evercore ISI

$250→$260

Buy

17.76%

Upside

Reiterated

02/06/26

Cardinal Health price target raised to $260 from $250 at Evercore ISICardinal Health price target raised to $260 from $250 at Evercore ISI

Brian Tanquilut

Jefferies

$220→$270

Buy

22.29%

Upside

Reiterated

01/22/26

Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Agios Pharma (NASDAQ: AGIO) and Henry Schein (NASDAQ: HSIC)

Allen Lutz

Bank of America Securities

$230→$240

Buy

8.70%

Upside

Reiterated

01/15/26

Cardinal Health price target raised to $240 from $230 at BofACardinal Health price target raised to $240 from $230 at BofA

Michael Cherny

Leerink Partners

$230→$240

Buy

8.70%

Upside

Reiterated

01/13/26

Cardinal Health price target raised to $240 from $230 at LeerinkCardinal Health price target raised to $240 from $230 at Leerink

Daniel Grosslight

Citi

$190→$244

Buy

10.51%

Upside

Upgraded

01/09/26

Cardinal Health upgraded to Buy from Neutral at CitiCardinal Health upgraded to Buy from Neutral at Citi

Steven Silver

Argus Research

$185→$189

Buy

-14.40%

Downside

Reiterated

08/22/25

Cardinal Health price target raised to $189 from $185 at ArgusCardinal Health price target raised to $189 from $185 at Argus

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Lisa Gill

J.P. Morgan

$243

Hold

10.06%

Upside

Reiterated

02/10/26

Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Biogen (NASDAQ: BIIB) and Quest Diagnostics (NYSE: DGX)

Charles Rhyee

TD Cowen

$233→$251

Buy

13.68%

Upside

Reiterated

02/10/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Cardinal Health (NYSE: CAH)

Steven Valiquette

Mizuho Securities

$235

Buy

6.44%

Upside

Reiterated

02/10/26

Mizuho Securities Keeps Their Buy Rating on Cardinal Health (CAH)

Stephen Baxter

Wells Fargo

$237→$256

Buy

15.95%

Upside

Reiterated

02/10/26

Cardinal Health price target raised to $256 from $237 at Wells FargoCardinal Health price target raised to $256 from $237 at Wells Fargo

Erin Wright

Morgan Stanley

$245→$255

Buy

15.49%

Upside

Reiterated

02/06/26

Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and Cardinal Health (NYSE: CAH)

Eric Coldwell

Robert W. Baird

$250→$252

Buy

14.14%

Upside

Reiterated

02/06/26

Cardinal Health price target raised to $252 from $250 at BairdCardinal Health price target raised to $252 from $250 at Baird

Glen Santangelo

Barclays

$243

Buy

10.06%

Upside

Reiterated

02/06/26

Barclays Remains a Buy on Cardinal Health (CAH)

Kevin Caliendo

UBS

$250→$260

Buy

17.76%

Upside

Reiterated

02/06/26

Cardinal Health price target raised to $260 from $250 at UBSCardinal Health price target raised to $260 from $250 at UBS

Elizabeth Anderson CFA

Evercore ISI

$250→$260

Buy

17.76%

Upside

Reiterated

02/06/26

Cardinal Health price target raised to $260 from $250 at Evercore ISICardinal Health price target raised to $260 from $250 at Evercore ISI

Brian Tanquilut

Jefferies

$220→$270

Buy

22.29%

Upside

Reiterated

01/22/26

Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Agios Pharma (NASDAQ: AGIO) and Henry Schein (NASDAQ: HSIC)

Allen Lutz

Bank of America Securities

$230→$240

Buy

8.70%

Upside

Reiterated

01/15/26

Cardinal Health price target raised to $240 from $230 at BofACardinal Health price target raised to $240 from $230 at BofA

Michael Cherny

Leerink Partners

$230→$240

Buy

8.70%

Upside

Reiterated

01/13/26

Cardinal Health price target raised to $240 from $230 at LeerinkCardinal Health price target raised to $240 from $230 at Leerink

Daniel Grosslight

Citi

$190→$244

Buy

10.51%

Upside

Upgraded

01/09/26

Cardinal Health upgraded to Buy from Neutral at CitiCardinal Health upgraded to Buy from Neutral at Citi

Steven Silver

Argus Research

$185→$189

Buy

-14.40%

Downside

Reiterated

08/22/25

Cardinal Health price target raised to $189 from $185 at ArgusCardinal Health price target raised to $189 from $185 at Argus

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardinal Health

3 Months

xxx

Success Rate

19/26 ratings generated profit

Average Return

+6.65%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 73.08% of your transactions generating a profit, with an average return of +6.65% per trade.

1 Year

Kevin CaliendoUBS

Success Rate

17/18 ratings generated profit

Average Return

+31.19%

a rating ―

Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 94.44% of your transactions generating a profit, with an average return of +31.19% per trade.

2 Years

xxx

Success Rate

17/18 ratings generated profit

Average Return

+73.13%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 94.44% of your transactions generating a profit, with an average return of +73.13% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CAH Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CAH has received 23 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CAH average Analyst price target in the past 3 months is 249.92.

Each month's total comprises the sum of three months' worth of ratings.

CAH Financial Forecast

CAH Earnings Forecast

Next quarter’s earnings estimate for CAH is $2.76 with a range of $2.67 to $3.01. The previous quarter’s EPS was $2.63. CAH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CAH has Performed in-line its overall industry.

CAH Sales Forecast

Next quarter’s sales forecast for CAH is $62.11B with a range of $60.40B to $64.25B. The previous quarter’s sales results were $65.63B. CAH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CAH has Performed in-line its overall industry.

CAH Stock Forecast FAQ

What is CAH’s average 12-month price target, according to analysts?

Based on analyst ratings, Cardinal Health’s 12-month average price target is 249.92.

What is CAH’s upside potential, based on the analysts’ average price target?

Cardinal Health has 13.19% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CAH a Buy, Sell or Hold?

Cardinal Health has a consensus rating of Strong Buy which is based on 12 buy ratings, 1 hold ratings and 0 sell ratings.

What is Cardinal Health’s price target?

The average price target for Cardinal Health is 249.92. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $270.00 ,the lowest forecast is $235.00. The average price target represents 13.19% Increase from the current price of $220.79.

What do analysts say about Cardinal Health?

Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of CAH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Cardinal Health (CAH) Stock Forecast & Price Target

CAH Analyst Ratings

CAH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cardinal Health

CAH Analyst Recommendation Trends

CAH Financial Forecast

CAH Earnings Forecast

CAH Sales Forecast

CAH Stock Forecast FAQ

Detailed List of Analyst Forecasts